Terms: = Kidney tumors AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Prognosis
6 results:
1. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract] [Full Text] [Related]
2. [Comparative morphological characteristics and immunophenotype of urothelial carcinomas of the renal pelvis and bladder].
Osmanov YI; Gaibov ZA; Kogan EA; Radenska-Lopovok SG; Tursunov KZ
Arkh Patol; 2018; 80(5):23-32. PubMed ID: 30335057
[TBL] [Abstract] [Full Text] [Related]
3. Ileocecal adenocarcinoma with overexpression of P53 protein metastasized to the thenar muscle: report of a rare case and review of literature.
Yi C; Liu Z; Chu Y; Li S; Liu L; Li J; Yu X
Int J Clin Exp Pathol; 2015; 8(10):13546-51. PubMed ID: 26722571
[TBL] [Abstract] [Full Text] [Related]
4. [Villous adenoma of the urinary tract: a clinicopathological study].
Yin W; Mo XL; Wen ZH; Zhou XZ; Zhou MY; Wei HM
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):438-41. PubMed ID: 24246860
[TBL] [Abstract] [Full Text] [Related]
5. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.
Köstner K; Denzer N; Müller CS; Klein R; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3511-36. PubMed ID: 19667145
[TBL] [Abstract] [Full Text] [Related]
6. [Treatment and prognosis of T 4 renal cell carcinoma].
Fukuda M; Satomi Y; Nakahashi M; Senga Y; Oogo Y; Udagawa K; Asakura T
Nihon Hinyokika Gakkai Zasshi; 1999 Sep; 90(9):753-62. PubMed ID: 10517083
[TBL] [Abstract] [Full Text] [Related]
